Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy

Measuring the Prevalence of Chronic Itch in the General Population: Development and Validation of a Questionnaire for Use in Large-scale Studies

(2009) U Matterne et al.   ACTA DERMATO-VENEREOLOGICA

Epidemiology of Itch: Adding to the Burden of Skin Morbidity

(2009) E Weisshaar et al.   ACTA DERMATO-VENEREOLOGICA

Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study

(2009) H. Kumagai et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Aprepitant as an Antipruritic Agent?

(2009) Arnaud Duval et al.   NEW ENGLAND JOURNAL OF MEDICINE

Significant differences in central imaging of histamine-induced itch between atopic dermatitis and healthy subjects

(2008) Gudrun Schneider et al.   EUROPEAN JOURNAL OF PAIN

Neurophysiological and neurochemical basis of modern pruritus treatment

(2008) Sonja Ständer et al.   EXPERIMENTAL DERMATOLOGY

Neuropeptides activate human mast cell degranulation and chemokine production

(2007) Marianna Kulka et al.   IMMUNOLOGY